348 related articles for article (PubMed ID: 17498532)
21. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan.
Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S
Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462
[TBL] [Abstract][Full Text] [Related]
22. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
[TBL] [Abstract][Full Text] [Related]
23. [Axillary lymph node recurrence after sentinel lymph node biopsy for breast cancer].
Mathelin C; Salvador S; Guyonnet JL
J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):253-9. PubMed ID: 17317037
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of axillary lymph node micrometastases in breast cancer.
Sakorafas GH; Geraghty J; Pavlakis G
Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
[TBL] [Abstract][Full Text] [Related]
25. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
[TBL] [Abstract][Full Text] [Related]
26. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
27. [Management of axillary and internal mammary lymph nodes in primary breast cancer].
Masuda N; Tamaki Y; Noguchi S
Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):465-72. PubMed ID: 11436509
[TBL] [Abstract][Full Text] [Related]
28. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
[TBL] [Abstract][Full Text] [Related]
29. Current status of sentinel lymph node biopsy in early breast cancer.
Jatoi I
Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
[TBL] [Abstract][Full Text] [Related]
30. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term.
Sanli I; Lemaire BM; Muller AJ; van Kleffens HJ; Van Poll-Franse LV; van Dijk M
Breast J; 2009; 15(3):236-41. PubMed ID: 19645777
[TBL] [Abstract][Full Text] [Related]
31. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of the axilla: do intramammary nodes matter?
Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
[TBL] [Abstract][Full Text] [Related]
33. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
Samphao S; Eremin JM; El-Sheemy M; Eremin O
Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
[TBL] [Abstract][Full Text] [Related]
34. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
[TBL] [Abstract][Full Text] [Related]
35. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
[TBL] [Abstract][Full Text] [Related]
36. Breast sentinel lymph node dissection before preoperative chemotherapy.
Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
[TBL] [Abstract][Full Text] [Related]
37. The role of nodal staging in breast cancer. Past, present and future.
Hirche C; Mohr Z; Kneif S; Hünerbein M
Minerva Chir; 2010 Oct; 65(5):537-46. PubMed ID: 21081865
[TBL] [Abstract][Full Text] [Related]
38. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
39. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
40. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
White RL; Wilke LG
Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]